Triumvira Immunologics
Austin, US
Biotech
Founders & leadership
CC
CYNTHIA COLLINS, MBADirector
SS
SCOTT SMITHDirector
DJ
DANIEL JANSEDirector
JE
JURGEN ECKHARDTDirector
TM
TERESA MCROBERTSExecutive Officer
PL
PAUL LAMMERS, MD, MScExecutive Officer, Director
EW
ELIZABETH WILLIAMSDirector
JI
JON IRVINExecutive Officer
WM
WIDYA MULYASASMITADirector
BM
BRIAN M. BLOOMDirector
LC
LEE COOPERDirector
Reported raises · per SEC filings
Form D private placements▶$59.7MraisedSep 2022 · 13 investors · BiotechnologyRule 506(b)
▶$59.7MraisedSep 2022 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CYNTHIA COLLINS, MBADirector
- SCOTT SMITHDirector
- DANIEL JANSEDirector
- JURGEN ECKHARDTDirector
- TERESA MCROBERTSExecutive Officer
- PAUL LAMMERS, MD, MScExecutive Officer, Director
- ELIZABETH WILLIAMSDirector
- JON IRVINExecutive Officer
- WIDYA MULYASASMITADirector
- BRIAN M. BLOOMDirector
- LEE COOPERDirector
- Offering amount
- $59.7M
- Amount sold
- $59.7M
- First sale
- Apr 2021
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.